MENU
+Compare
SEPSF
Stock ticker: OTC
AS OF
Jan 14 closing price
Price
$0.05
Change
+$0.02 (+66.67%)
Capitalization
2.4M

SEPSF ASEP Medical Holdings Inc. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
SEPSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SEPSF with price predictions
Jan 08, 2025

Momentum Indicator for SEPSF turns positive, indicating new upward trend

SEPSF saw its Momentum Indicator move above the 0 level on January 03, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator turned positive. In of the 16 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.475) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). SEPSF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (19.646) is also within normal values, averaging (264.079).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SEPSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SEPSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SEPSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
730 View Street
Phone
+1 778 600-0509
Employees
N/A
Web
https://www.asepmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOSIX60.790.60
+1.00%
Northern Stock Index
ISCAX38.950.21
+0.54%
Federated Hermes Intl Small-Mid Co A
GIIAX8.650.03
+0.35%
Nationwide International Index A
LADSX23.070.07
+0.30%
Lord Abbett Developing Growth R4
PRKZX7.40-0.02
-0.27%
PGIM Real Estate Income Z

SEPSF and Stocks

Correlation & Price change

A.I.dvisor tells us that SEPSF and VTYX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SEPSF and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEPSF
1D Price
Change %
SEPSF100%
N/A
VTYX - SEPSF
29%
Poorly correlated
+6.88%
CLVLF - SEPSF
25%
Poorly correlated
N/A
ALGS - SEPSF
24%
Poorly correlated
+8.32%
BVAXF - SEPSF
21%
Poorly correlated
+1.88%
ALLR - SEPSF
14%
Poorly correlated
+1.94%
More